Add this result to my export selection What are the benefits and harms of exercise for women with dysmenorrhea? Source: Cochrane Clinical Answers (Remove filter) 27 December 2019 Question: What are the benefits and harms of exercise for women with dysmenorrhea? Carlos Fernando Grillo‐Ardila... Type: Systematic Reviews (Remove filter)
Add this result to my export selection Long-acting reversible contraception: levonorgestrel 13.5 mg intrauterine delivery system - evidence summary (ESNM41) Source: National Institute for Health and Care Excellence - NICE (Remove filter) 04 June 2014 Summary of the evidence on the levonorgestrel intrauterine delivery system (long-acting reversible contraception) to inform local NHS planning... Type: Evidence Summaries (Remove filter)
Add this result to my export selection For adults with acute pain, what are the benefits and harms of caffeine as an analgesic adjuvant? Source: Cochrane Clinical Answers (Remove filter) 16 November 2017 maximum possible pain relief, 6 hours ‐ Dysmenorrhea Narrative result One RCT with 620 participants with dysmenorrhea found... Type: Systematic Reviews (Remove filter)
Add this result to my export selection What are the benefits and harms of mifepristone in women with endometriosis? Source: Cochrane Clinical Answers (Remove filter) 24 November 2017 reveals that mifepristone (2.5, 5, or 10 mg daily for 6 months) decreased dysmenorrhea (on average, 51 vs 402 per 1000 women) and... Type: Systematic Reviews (Remove filter)
Add this result to my export selection Improving health and learning through better water, sanitation and hygiene in schools. An information package for school staff (2019) (PDF) Source: WHO Regional Office for Europe - WHO Europe (Remove filter) 01 November 2019 groups in the case of health problems, such as hormonal imbalances or dysmenorrhoea, that cannot be resolved at school. n If... Type: Evidence Summaries (Remove filter)
Add this result to my export selection What are the benefits and harms of treatments for pain and subfertility in women with endometriosis? Source: Cochrane Clinical Answers (Remove filter) 05 December 2016 One systematic review reported no apparent difference between groups in dysmenorrhea at 6 or 12 months when laparoscopic surgery was... Type: Systematic Reviews (Remove filter)
Add this result to my export selection Caesarean section : Evidence Update March 2013 Source: National Institute for Health and Care Excellence - NICE (Remove filter) Published by National Institute for Health and Care Excellence (NICE), 01 March 2013 Caesarean section : Evidence Update March 2013 Evidence Updates provide a summary of selected new evidence published since the literature search was last conducted for the accredited guidance they... Read Summary Type: Evidence Summaries (Remove filter)
Add this result to my export selection Can non‐contraceptive estrogen‐progestogen‐containing preparations control symptoms of premenstrual syndrome? Source: Cochrane Clinical Answers (Remove filter) 02 October 2017 (bleeding problems, breast tenderness, headache, nausea, weight gain, dysmenorrhea, or skin reactions) in women receiving estrogen plus... Type: Systematic Reviews (Remove filter)
Add this result to my export selection For women with heavy menstrual bleeding, how do antifibrinolytics compare with placebo? Source: Cochrane Clinical Answers (Remove filter) 23 August 2018 gastrointestinal effects, headache, uterine cancer, vaginal dryness, dysmenorrhea, thromboembolic events, or anemia. Most of the events... Type: Systematic Reviews (Remove filter)
Add this result to my export selection For women with heavy menstrual bleeding, how does tranexamic acid (TXA) compare with progestogens? Source: Cochrane Clinical Answers (Remove filter) 23 August 2018 assessed (gastrointestinal, vertigo, headache, bleeding, breast tenderness, dysmenorrhea, weight gain, allergic reaction, giddiness,... Type: Systematic Reviews (Remove filter)